Amazonian biodiversity is an underexploited source of bioactive natural products with potential relevance to drug discovery for neglected diseases. Here, we characterized the chemistry and multi-target in vitro activity of an ethyl acetate extract from Dinizia excelsa wood. Extraction yielded 4.84 ± 0.10% and produced a phenolic-rich fraction with high total phenolics (501.8 ± 1.0 mg GAE/g extract), flavonoids (172.4 ± 0.8 mg QE/g), flavonols (49.7 ± 0.3 mg QE/g), and hydrolyzable tannins (229.4 ± 1.2 mg TAE/g). LC-HRMS dereplication annotated 19 metabolites, dominated by glycosylated flavonoids (rutin, isoquercetin), phenolic acids (ferulic and ellagic acids), ellagic derivatives (urolithins), and galloylated hydrolyzable tannins. The extract showed moderate-to-low antioxidant capacity across complementary assays (IC₅₀ 78.38-161.99 µg/mL) and a favorable safety profile, with moderate/low cytotoxicity in mammalian cell lines (IC₅₀ 364-700 µg/mL) and minimal hemolysis (<6% up to 1000 µg/mL). In murine splenocytes, the extract preserved membrane integrity, induced dose-dependent proliferation, and promoted a broad but controlled cytokine response (↑IL-2, IL-4, IL-10, IL-12, IFN-γ, IL-17, TNF-α; regulated TGF-β), alongside reduced NO, mild cytosolic ROS modulation, and stable mitochondrial membrane potential. Notably, it displayed strong antiparasitic activity against Trypanosoma cruzi (IC₅₀ 2.37-3.94 µg/mL) and Leishmania spp. (IC₅₀ 1.83-6.43 µg/mL), with additional activity against Schistosoma mansoni (IC₅₀ 114.83-247.0 µg/mL) and Plasmodium falciparum 3D7 (IC₅₀ 5438.27 ng/mL). Antibacterial MICs ranged 16-512 µg/mL and antifungal MICs 16-256 µg/mL, consistent with bacteriostatic/fungistatic effects.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: